نتائج البحث

Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors

• Authors : Melanoma Research Alliance; Rising Tide Foundation

• Source: Phase I Study of Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors

تفاصيل العنوان

War on Melanoma™ Public Health & Education Campaign

• Authors : Melanoma Research Foundation; Oregon Health and Science University; Sancy A Leachman, MD, PhD, Principal Investigator

• Source: Educational Program for the Early Detection of Melanoma in Oregon

تفاصيل العنوان

Duration of Anti-PD-1 Therapy in Metastatic Melanoma (STOP-GAP)

• Authors : Melanoma and Skin Cancer Trials Limited

• Source: A Randomized Phase III Trial of the Duration of Anti-PD-1 Therapy in Metastatic Melanoma

تفاصيل العنوان

Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families

• Authors : National Cancer Institute (NCI); Sharon Manne, PhD, Professor of Medicine

• Source: Facebook Intervention for Young Onset Melanoma Patients and Families

تفاصيل العنوان

NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma (NeoLIPA)

• Authors : Lytix Biopharma AS; Henrik Jespersen, Head of Melanoma Oncology, Group Leader Melanoma Research

• Source: NeoLIPA: a Single Center Phase II Open Label Study of Neoadjuvant LTX-315 in Combination with Pembrolizumab in Patients with Clinically Detectable and Resectable Stage III-IV

تفاصيل العنوان

Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers

• Authors : National Center for Advancing Translational Sciences (NCATS)

• Source: Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers

تفاصيل العنوان

Evaluation of a Personalised Survivorship Care Plan App for Patients with Melanoma (Melanoma SCP)

• Authors : BeterKeten; Albert Schweitzer Hospital; Maasstad Hospital ...

• Source: Personalised Survivorship Care for Patients with Melanoma: a Multicenter Randomised Controlled Trial of the Survivorship Care Plan App

تفاصيل العنوان

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Melanoma (Morpheus-Melanoma)

• Source: A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Melanoma

تفاصيل العنوان

A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma

• Source: Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV

تفاصيل العنوان

Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV Melanoma

• Authors : National Cancer Institute (NCI)

• Source: A Phase II Study of the TRIplet Combination of Dabrafenib, Nivolumab, and Trametinib in Patients With Metastatic Melanoma (TRIDeNT) or Binimetinib, EnCorafenib, and

تفاصيل العنوان